← Leaderboards
Sandra L Dabora
Dana-Farber Cancer Institute
$3,836,592
Attributed
$3,836,592
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $690.5K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$3,836,592 · 5
By mechanism
R01$2,707,186 · 2
R33$920,400 · 1
R21$120,850 · 1
K08$88,156 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- William C Hahn$46,384,528
- A Thomas Look$30,189,128
- Charles Stiles$20,855,954
- Robert William Finberg$14,464,760
Others in their field
Top investigators on “Tuberous Sclerosis”
- Elizabeth P Henske · Brigham And Women'S Hospital$23,271,457
- David J. Kwiatkowski · Brigham And Women'S Hospital$16,276,792
- Vera P Krymskaya · University Of Pennsylvania$15,930,472
- Brendan D. Manning · Harvard School Of Public Health$14,104,920
- Mustafa None Sahin · Children'S Hospital Boston$12,977,961
- Darcy Krueger · Boston Children'S Hospital$10,517,407
Research focus
Tuberous SclerosisClinical ResearchFamily GeneticsTumorRenal AngiomyolipomaAutosomal Dominant TraitMental Disorder DiagnosisGenetic Disorder DiagnosisHigh Throughput TechnologyLesionNervous System Disorder DiagnosisPharmaceutical PreparationsDefectSirolimusCystic KidneyDiagnosis Design /EvaluationGenetic ScreeningGene Deletion MutationGenotypeHigh Performance Liquid ChromatographyHuman SubjectKidneyKidney NeoplasmsVascular Endothelial Growth Factors
Grant awards (14)
IFN gamma and other modifiers of kidney disease in TSC$255,476
R01 · FY2008 · DK · contact PI
Multicenter clinical trials for TSC & related disorders$181,066
R01 · FY2008 · CA · contact PI
Multicenter clinical trials for TSC & related disorders$332,328
R01 · FY2007 · CA · contact PI
IFN gamma and other modifiers of kidney disease in TSC$320,313
R01 · FY2007 · DK · contact PI
Multicenter clinical trials for TSC & related disorders$336,862
R01 · FY2006 · CA · contact PI
IFN gamma and other modifiers of kidney disease in TSC$331,103
R01 · FY2006 · DK · contact PI
Multicenter clinical trials for TSC &related disorders$349,978
R01 · FY2005 · CA
IFN gamma and other modifiers of kidney disease in TSC$340,544
R01 · FY2005 · DK
IFN gamma and other modifiers of kidney disease in TSC$259,516
R01 · FY2004 · DK
MUTANT ANALYSIS OF TSC1 &TSC2 IN TSC RELATED DISORDERS$315,912
R33 · FY2003 · CA
MUTANT ANALYSIS OF TSC1 &TSC2 IN TSC RELATED DISORDERS$306,710
R33 · FY2002 · CA
MUTANT ANALYSIS OF TSC1 &TSC2 IN TSC RELATED DISORDERS$297,778
R33 · FY2001 · CA
MUTANT ANALYSIS OF TSC1 &TSC2 IN TSC RELATED DISORDERS$120,850
R21 · FY2000 · CA
SPINDLE DYNAMICS AND CHROMOSOME MOVEMENT DURING ANAPHASE$88,156
K08 · FY2000 · CA